CXCL8 and melanoma: Upregulation of IL-8 secretion and MMP-2 activity was also reported by Sandri et al. [37] in melanoma cells with acquired resistance to vemurafenib, and our data are consistent with those findings and with the knowledge that MMP-2 activity is promoted by IL-8 expression [38].